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Abstract
Multiple diagnostic tests are often used due to limited resources or because they provide
complementary information on the epidemiology of a disease under investigation. Existing stat-
istical methods to combine prevalence data from multiple diagnostics ignore the potential over-
dispersion induced by the spatial correlations in the data. To address this issue, we develop a
geostatistical framework that allows for joint modelling of data from multiple diagnostics by con-
sidering two main classes of inferential problems: (1) to predict prevalence for a gold-standard
diagnostic using low-cost and potentially biased alternative tests; (2) to carry out joint prediction
of prevalence from multiple tests. We apply the proposed framework to two case studies: map-
ping Loa loa prevalence in Central and West Africa, using miscroscopy and a questionnaire-based
test called RAPLOA; mapping Plasmodium falciparum malaria prevalence in the highlands of
Western Kenya using polymerase chain reaction and a rapid diagnostic test. We also develop a
Monte Carlo procedure based on the variogram in order to identify parsimonious geostatistical
models that are compatible with the data. Our study highlights (i) the importance of accounting
for diagnostic-specific residual spatial variation and (ii) the benefits accrued from joint geostat-
istical modelling so as to deliver more reliable and precise inferences on disease prevalence.
Keywords: disease mapping; geostatistics; malaria; neglected tropical disesaes; multiple dia-
gnostic tests; prevalence.
1 Introduction
Disease mapping denotes a class of problems in public health where the scientific goal is to predict
the spatial variation in disease risk on a scale that can range from sub-national to global (Murray
et al., 2014; Liu et al., 2012). Understanding the geographical distribution of a disease is particularly
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important in the decision-making process for the planning, implementation, monitoring and evalu-
ation of control programmes (World Health Organization, 2017; Bhatt et al., 2015). In this context,
model-based geostatistical methods (Diggle et al., 1998) have been especially useful in low-resource
settings (Diggle and Giorgi, 2016; Gething et al., 2012; Zouré et al., 2014) where disease registries
are non-existent or geographically incomplete, and monitoring of the disease burden is carried out
through cross-sectional surveys and passive surveillance systems.
It is often the case that prevalence data from a geographical region of interest are obtained using
different diagnostic tests for the same disease under investigation. The reasons for this are manifold.
For example, when the goal of geostatistical analysis is to map disease risk on a continental or global
scale by combining data from multiple surveys, dealing with the use of different diagnostic tests
may be unavoidable. In other cases, gold-standard diagnostic tests are often expensive and require
advanced laboratory expertise and technology which may not always be available in constrained re-
source settings. This requires the use of more cost-effective alternatives for disease testing in order
to attain a required sample size. Different diagnostics might also provide complementary informa-
tion of intrinsic scientific interests into the spatial variation of disease risk and the distribution of
hotspots.
In the absence of statistical methods that allow for the joint analysis of multiple diagnostics,
most studies have reported separate analyses. A shortcoming of this approach is that it ignores, and
therefore fails to explain, possible correlations between prevalence of different diagnostics. Statistical
inference might benefit from a joint analysis, which can yield more efficient estimation of regression
parameters (Song et al., 2009) and more precise predictions of prevalence.
However, different diagnostic tests can exhibit considerable disparities in the estimates of disease
prevalence for the same population, or even the same individuals. Obvious sources of such variation
include differences in sensitivity and specificity. Furthermore, different diagnostics may exhibit
differences in their association with the same risk factors. In a geostatistical context, there may
also be differences between the spatial covariance structures of different diagnostics.
These aspects highlight the potential challenges that joint modelling of multiple diagnostics
needs to take into account. In this paper, we address such issues in order to develop a general
framework for geostatistical analysis and describe the application of this framework to Loa loa and
malaria mapping in Africa.
The structure of the paper is as follows. In Section 2, we describe the two motivating ap-
plications. In Section 3, we review existing methods for combining prevalence data from different
diagnostics. In Section 4, we introduce a geostatistical framework for combining data from two
diagnostics and distinguish two main classes of problems that arise in this context. In Sections 5
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and 6, we apply this framework to the two case studies introduced in Section 2. In Section 7, we
discuss methodological extensions to more than two diagnostics.
2 Motivating applications
2.1 Loa loa mapping in Central and West Africa
Loiasis is a neglected tropical disease that has received an increased attention due to its impact on
the control of a more serious infectious disease, onchocerciasis, that is endemic in large swathes of
sub-Saharan Africa. Mass administration of the drug ivermectin confers protection against oncho-
cerciasis, but individuals who are highly co-infected with Loa loa - the Loiasis parasite - can develop
severe and occasionally fatal adverse reaction to the drug (Boussinesq et al., 1998).
Boussinesq et al. (2001) have shown that high levels in Loa loa prevalence within a community
are strongly associated with a high parasite density. For this reason, Zouré et al. (2011) have
suggested that precautionary measures should be put in place before the roll-out of mass drug
administration with ivermectin in areas where prevalence of infection with Loa loa is greater than
20%.
In order to carry out a rapid assessment of the Loa loa burden in endemic areas a questionnaire
instrument, named RAPLOA, was developed as a more economically feasible alternative to the
standard microscopy-based microfilariae (MF) detection in blood smears (Takougang et al., 2002).
To validate the RAPLOA methodology against microscopy, cross-sectional surveys using both dia-
gnostics were carried out in four study sites in Cameroon, Nigeria, Republic of Congo and the
Democratic Republic of Congo (see Wanji et al. (2012) and Additional Figure 1 in Web Appendix
B).
In this study, the objective of statistical inference is to develop a calibration relationship between
the two diagnostic procedures. This could then be applied to map microscopy-based MF prevalence
in areas where the more economical RAPLOA questionnaire is the only feasible option.
2.2 Malaria mapping in the highlands of Western Kenya
Malaria continues to be a global public health challenge, especially in sub-Sharan Africa which,
in 2016, accounted for about 90% of all the 445,000 estimated malaria deaths worldwide (World
Health Organization, 2017). Polymerase chain reaction (PCR) and a rapid diagnostic test (RDT)
are two of the most commonly used procedures for detecting Plasmodium falciparum, the deadliest
species of the malaria parasites. PCR is highly sensitive and specific, but its use is constrained by
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high costs and the need for highly trained technicians. RDT is simpler to use, cost-effective and
requires minimal training, but is less sensitive than PCR (Tangpukdee et al., 2009). Recent studies
have reported that PCR and RDT can lead to the identification of different malaria hotspots, i.e.
areas where disease risk is estimated to be unexpectedly high (Mogeni et al., 2017). In this context,
mapping of both diagnostics is of epidemiological interest since their effective use is dependent on
the level of malaria transmission, with PCR being the preferred testing option in low-transmission
settings (Mogeni et al., 2017).
In order to investigate this issue, a malariometric survey was conducted using both RDT and
PCR in two highland districts of Western Kenya (see Additional Figure 2 in Web Appendix B); see
Stevenson et al. (2015) for a descriptive analysis of this study. In this scenario, a joint model for
the reported malaria counts from the two diagnostics could allow to exploit their cross-correlation
and identify malaria hotspots more accurately.
3 Literature review
We formally express the format of geostatistical data from multiple diagnostics as
D = {(xik, nik, yijk) : j = 1, . . . , nik; i = 1, . . . , N ; k = 1, . . . ,K} (3.1)
where yijk is a binary outcome taking value 1 if the j-th individual at location xik tests positive for
the disease under investigation using the k-th diagnostic procedure, and 0 otherwise. We use pijk
to denote the probability that an individual has a positive test outcome from the k-th diagnostic.
When data are only available as aggregated counts, we replace yijk in (3.1) with yik =
∑nik
j=1 yijk and
pijk with pik. When all diagnostic tools are used at each location, we replace xik with xi, although
this is not a requirement in the development of our methodology.
In the remainder of this section, we review non-spatial methods for joint modelling of the pijk
across multiple diagnostics and a geostatistical modelling approach proposed by Crainiceanu et al.
(2008).
3.1 Non-spatial approaches
Existing non-spatial methods for the analysis of data from multiple diagnostics fall within two main
classes of statistical models: generalised linear models (GLMs) and their random-effects counterpart,
generalised linear mixed models (GLMMs).
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Mappin et al. (2015) analysed data on P. falciparum prevalence from RDT and microscopy
outcomes from sub-Saharan Africa, using a standard probit model
Φ−1(pi1) = β0 + β1Φ−1(pi2), (3.2)
thus assuming a linear relationship between the pik on the probit scale. Wanji et al. (2012) used a
similar approach for Loa loa in order to study the relationship between microscopy and RAPLOA
prevalence by replacing the probit link in (3.2) with the logit. This model was also used by Wu et al.
(2015) to estimate the relationship between RDT, microscopy and PCR, for each pair of diagnostics.
A major limitation of these approaches based on standard GLMs is that they do not account for
any over-dispersion that might be induced by unmeasured risk factors.
Coffeng et al. (2013) proposes a bivariate GLMM for joint modelling of data on onchocerciasis
nodule prevalence and skin MF prevalence in adult males sampled across 148 villages in 16 African
countries. More specifically, the linear predictor of such model can be expressed as
log
{
pijk
1− pijk
}
= d>ijβk + Zi + Vij , (3.3)
where the random effects terms Zi and Vij are zero-mean Gaussian variables accounting for unex-
plained variation between-villages and between-individuals within villages, respectively. Using this
approach, Coffeng et al. (2013) estimated a strong positive correlation between nodule and MF
prevalence but also reported a variation in the strength of this relationship across study sites.
3.2 The Crainiceanu, Diggle and Rowlingson model
Crainiceanu et al. (2008) proposed a bivariate geostatistical model (henceforth CDRM) to analyse
data on microscopy and RAPLOA Loa loa prevalence (see Section 2.1). To the best of our knowledge,
this is the only existing approach that attempts to model the spatial correlation between two
diagnostics.
Let k = 1 correspond to the RAPLOA questionnaire, and k = 2 to microscopy. To emphasize
the spatial context, we now write pij = pj(xi); CDRM can then be expressed aslogit{p1(xi)} = d
>(xi)β + S(xi)
logit{p2(xi)} = α0 + α1logit{p1(xi)}+ Zi,
(3.4)
where logit(u) = log{u/[1−u]}, d(xi) is a vector of spatially varying covariates, S(xi) is a zero-mean
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stationary and isotropic Gaussian process and the Zi are zero-mean independent and identically
distributed Gaussian random variables. Crainiceanu et al. (2008) also provide empirical evidence
to justify the assumption of a logit-linear relationship between the two diagnostics.
A limitation of the CDRM is that it assumes proportionality on the logit scale between the
residual spatial fields associated with RAPLOA and microscopy. In our re-analysis in Section 5, we
use a Monte Carlo procedure to test this hypothesis.
4 Two classes of bivariate geostatistical models
We now develop two modelling strategies that address the specific objectives of the two case studies
introduced in Section 2. Our focus in this section will be restricted to the case of two diagnostics
(hence K = 2). We discuss the extension to more than two in Section 7.
4.1 Case I: Predicting prevalence for a gold-standard diagnostic
Let S1(x) and S2(x) be two independent stationary and isotropic Gaussian processes; also, let f1{·}
and f2{·} be two functions with domain on the unit interval [0, 1] and image on the real line. We
propose to model data from two diagnostics, with k = 2 denoting the gold-standard, asf1{p1(xi)} = d
>(xi)β1 + S1(xi) + Zi1
f2{p2(xi)} = d>(xi)β2 + S2(xi) + Zi2 + αf1{p1(xi)}.
(4.1)
In our applications, we specify exponential correlation functions for Sk(x), k = 1, 2, hence
cov{Sk(x), Sk(x′)} = σ2k exp{‖x− x′‖/φk},
where σ2k is the variance of Sk(x) and φk is a scale parameter regulating how fast the spatial
correlation decays to zero for increasing distance. Finally, we use τ2k to denote the variance of the
Gaussian noise Zik.
Selection of suitable functions f1 and f2 can be carried out, for example, by exploring the asso-
ciation between the empirical prevalences of the two diagnostics in order to identify transformations
that render their relationship approximately linear. Alternatively, subject matter knowledge could
be used to constrain the admissible forms for f1 and f2; see, for example, Irvine et al. (2016)
who derive a functional relationship between MF and an immuno-chromatographic test for preval-
ence of lymphatic filariasis by making explicit assumptions on the distribution of worms and their
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reproductive rate in the general population.
The proposed model in (4.1) is more flexible than the CDRM because (i) it allows for diagnostic-
specific unstructured variation Zik and, more importantly, (ii) relaxes the assumption of propor-
tionality between the residual spatial fields of the two diagnostics through the introduction of S2(x).
4.2 Case II: Joint prediction of prevalence from two complementary diagnostics
Let S1(x) and S2(x) be two independent Gaussian processes, and Zik Gaussian noise, each having
the same properties as defined in the previous section. We now introduce a third stationary and
isotropic Gaussian process T (x) having unit variance and exponential correlation function with scale
parameter φT .
Our proposed approach for joint prediction of prevalence from two diagnostics, when both are
of interest, is expressed by the following equation for the linear predictor
fk{pjk(xi)} = d>ijβk + νk
[
Sk(xi) + T (xi)
]
+ Zik. (4.2)
The spatial processes Sk(x) and T (x) accounts for unmeasured risk factors that are specific to each
and common to both diagnostics, respectively. The resulting variogram for the linear predictor is
γk(u) = E
[{(
νk
(
Sk(x) + T (x)
)
+ Zk(x)
)
−
(
νk
(
Sk(x′) + T (x′)
)
+ Zk(x′)
)}2]
= τ2k + ν2k
[
1− exp(−u/φT
)
+ σ2k
{
1− exp (−u/φSk)}], (4.3)
and the cross-variogram between the linear predictors of the two diagnostics is
γ1,2(u) = E
[{(
ν1
(
S1(x) + T (x)
)
+ Zk(x)
)
−
(
ν2
(
S2(x′) + T (x′)
)
+ Zk(x′)
)}2]
= 0.5{τ21 + τ22 + ν21(1 + σ21) + ν22(1 + σ22)} − σ1σ2 exp(−u/φT ). (4.4)
Given the relatively large number of parameters, fitting the model may require a pragmatic
approach. In order to identify a parsimonious model for the data, we recommend an incremental
modelling strategy, whereby a simpler model is used in a first analysis (e.g. by setting Sk(x) = 0
for all x) and more complexity is then added in response to an unsatisfactory validation check, as
described below.
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Figure 4.1: Directed acyclic graphs for the bivariate geostatistical models in (4.1) (left panel) and
(4.2) (right panel). Circles and squares identify latent variables and the outcome random variables,
respectively.
4.3 Comparison between the two models
Figure 4.1 gives two directed acyclic graph representations of the models in (4.1) (left panel) and
(4.2) (right panel), showing their distinctive asymmetric and symmetric structures. In the first
model, stochastic independence between the two diagnostics is simply recovered by setting the
parameter α = 0. If this is a scientifically relevant hypothesis, we can test it through the likelihood
ratio. In the second model, independence can only be achieved if T (x) = 0 for all x. We do not
consider this to be a credible assumption for the malaria application of Section 2.1.
4.4 Inference and model validation
We carry out parameter estimation for both the asymmetric and symmetric models using Monte
Carlo Maximum Likelihood (MCML) (Geyer, 1991; Christensen, 2004). To carry out spatial pre-
dictions at a set of unobserved locations, we plug the MCML estimates into a Markov Chain Monte
Carlo algorithm for simulation from the distribution of the random effects conditional on the data.
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We summarise our predictive inferences on prevalence using the mean, standard deviation, and
exceedance probabilities, i.e. the probability that the predictive distribution of prevalence exceeds
a predefined threshold. Details of the derivation and approximation of the log-likelihood function
are given in Web Appendix A.
For model validation we propose the following procedure. We first re-write both models in
general form
fk{pjk(xi)} = µijk +Wk(xi), (4.5)
where µijk is the mean component expressed as a regression on the available covariates. In (4.5),
if we set W1(xi) = S1(x) + Zi1 and W2(xi) = S2(xi) + Zi2 + α{f1(xi)}, then (4.5) reduces to the
asymmetric model (4.1); if, instead, Wk(xi) = νk
(
Sk(xi) + T (xi)
)
+ Zik, we recover the symmetric
model (4.2).
We define the empirical variogram of Wk(x) to be
γˆk(u) =
1
2|N(u)|
∑
(i,j)∈N(u)
{
Wˆk(xi)− Wˆk(xj)
}2
, (4.6)
where N(u) = {(i, j) : ||xi − xj || = u, i 6= j} and Wˆk(xi) is the mean of distribution of Wk(xi)
conditioned to the data. To test whether the adopted spatial structure for Wk(x) is compatible
with the data, we then proceed through the following steps.
Step 0. Obtain Wˆk(xi) from two separate standard geostatistical models (i.e. Wk(xi) = Sk(xi) +Zik,
where Sk(x), k = 1, 2 are independent processes) and compute the empirical variogram γˆk,
for k = 1, 2.
Step 1. Simulate prevalence data as in (3.1) from the adopted model for Wk(x) by plugging-in the
MCML estimates. Fit separate standard geostatistical models as in Step 0 and compute the
empirical variogram for the simulated dataset.
Step 2. Repeat Step 1 a large enough number of times, say M .
Step 3. Use the resulting M empirical variograms to generate 95% confidence intervals at each of a
set of pre-defined distance bins.
If the empirical variogram in Step 0 falls fully or partly outside the 95% confidence intervals, we
conclude that the model is not able to capture the spatial structure of the data satisfactorily.
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5 Application I: Re-analysis of the Loa loa data
A total of 223 villages were sampled in the four study sites (see Web Figure 1 in Web Appendix
B). The empirical prevalences from the RAPLOA and microscopy tests show a clear, approximately
linear relationship when both are logit-transformed (see Web Figure 3 in Web Appendix B). Each
of the two also exhibits a highly non-linear relationship with surface elevation (see Web Figure 4 in
Web Appendix B), which we capture using a piecewise linear spline with knots at 750 meters and
1015 meters.
We consider the two following models.
• Model 1: a slightly modified, more flexible, version of the CDRM, given bylogit{p1(xi)} = µ1(xi) + S1(xi) + Zi1logit{p2(xi)} = µ2(xi) + αlogit{p1(xi)}+ Zi2 , (5.1)
where
µk(xi) = βk,0 + βk,1 min{e(xi), e1}+ βk,2I(e(xi) > e1) min{e(xi)− e2, e2 − e1}
+βk,3 max{e(xi)− e2, 0}, k = 1, 2,
where e(x) denotes the elevation in meters at location x, e1 = 750, e2 = 1015 and I(P) is an
indicator function which takes value 1 if P is true and 0 otherwise. In this parameterisation,
βk,1 is the effect of elevation on prevalence below 750 meters, βk,2 its effect between 760 and
1015 meters, and βk,3 its effect above 1015 meters.
• Model 2: obtained by incorporating an additional spatial process S2(x), independent of S1(x),
into the linear predictor for microscopy in Model 1 to give
logit{p2(xi)} = µ2(xi) + S2(xi) + αlogit{p1(xi)}+ Zi2 (5.2)
5.1 Results
Table 1 reports the MCML estimates obtained for Models 1 and 2. We observe that all parameters
common to both Models 1 and Model 2 have comparable point and interval estimates, except for
τ21 which has a substantially narrower 95% confidence interval under Model 1 than Model 2.
As expected, both models show a significant and positive logit-linear relationship between
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RAPLOA and miscroscopy. However, Model 2, which include the additional spatial process S2(x),
is also able to capture spatial variation in microscopy prevalence on a scale of about 24 meters.
We use the validation procedure of Section 6.1 to test which of the two models better fits the
spatial structure of the data. The results (see Web Figure 5) show a satisfactory assessment of
Model 2, whereas for Model 1 the empirical variogram for microscopy partly falls outside the 95%
confidence band, questioning its validity.
We now compare the predictive inferences on microscopy prevalence between the two models in
order to assess whether the introduction of S2(x) makes a tangible difference. Figure 5.1 shows the
point estimates for microscopy prevalence and the exceedance probabilities for a 20% prevalence
threshold under Model 1 (upper panels), under Model 2 (middle panels), and the difference between
the two (lower panels). Overall, the predicted spatial pattern in prevalence from the two models
is similar, but with substantial local differences. The difference between the point estimates for
prevalence ranges from -0.12 to 0.13, while the difference between the two exceedance probabilities
ranges from -0.44 to 0.59.
5.2 Simulation Study
We carry out a simulation study in order to quantify the effects on the predictive inferences for
prevalence when ignoring microscopy-specific residual spatial variation. To this end, we compare
the predictive performances of Model 1 and Model 2 at 20 unobserved locations corresponding to
the centroids of 20 clusters (shown as red points in Web Figure 1) that we identify using the k-
means algorithm (Hartigan and Wong, 1979) and proceed as follows. We simulate 10,000 Binomial
data-sets under Model 2 by setting its parameters to the estimates of Table 1 and fit both models.
We then carry out predictions for microscopy prevalence over the 20 unobserved locations. We
summarise the results at each of the 20 prediction locations using the 95% coverage probability
(CP), the root-mean-square-error (RMSE) and the 95% predictive interval length (PIL). Table 2
shows the three metrics averaged over the 20 locations for Model 1 and Model 2. The CP of Model
1 (77.5%) is well below its nominal level of 95%. This is also reflected by a smaller PIL for Model
1, suggesting that this provides unreliably narrow 95% predictive intervals for prevalence. Finally,
we note that Model 1 also has a larger RMSE than Model 2.
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Prevalence (Model 1) Exceedance probs. (Model 1)
Prevalence (Model 2) Exceedance probs. (Model 2)
Difference in prevalence Difference in exceedance probs.
Figure 5.1: Predictive mean of Loa loa microfilariae prevalence (left panels) and probabilities of
exceeding a 20% prevalence threshold (right panels), for Model 1 (top panels) and Model 2 (middle
panels) of Section 5. The bottom panels show the differences between the predictive surfaces of
Model 2 and Model 1.
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6 Application II: Joint prediction of Plasmodium falciparum pre-
valence using RDT and PCR
The malaria data consist of 3,587 individuals sampled across 949 locations (see Web Figure 2). The
outcomes from RDT (k = 1) and PCR (k = 2) were concordant in 92.4% of all the individuals
tested for P. falciparum. This suggests that estimating components of residual spatial variation
that are unique to each diagnostic may be difficult. For this reason our model for the data takes
the following form
fk(pjk(xi)) = βk,0 +
3∑
l=1
βk,ldij,l + νkT (xi), (6.1)
where: dij,1 is a binary variable taking value 1 if the j-th individual at xi is a male and 0 otherwise;
dij,2 = min{aij , 5} and dij,3 = max{aij − 5, 0}, i.e. the effect of age, aij , is modelled as a linear
spline with a knot at 5 years.
6.1 Results
Table 3 reports point estimates and 95% confidence intervals for the model parameters. Gender
has a significant effect on PCR prevalence, but its effect on RDT prevalence is not significant at
the conventional 5% alpha level. The effect of age is comparable between the two diagnostics,
with the probability of a positive test increasing with age up to 5 years and decreasing thereafter.
The estimated variance component, νˆ21 = 0.230, associated with RDT is about three times that
for PCR, νˆ22 = 0.081. The spatial process T (x), common to both diagnostics, accounts for spatial
variation in malaria prevalence up to a scale of about 11.6 kilometers, beyond which the correlation
falls below 0.05. The variogram-based validation procedure of Section does not show any strong
evidence against the fitted model (see Web Figure 6 in Web Appendix B).
To quantify the benefit of carrying out a joint analysis for RDT and PCR, we compare the
predictive inferences for prevalence that are obtained under two scenarios: (i) the fitted model in
(6.1); (ii) separate fitted models that ignore the cross-correlation between the outcomes of the two
diagnostic tests. Figure 6.1 shows the point predictions and standard errors for RDT and PCR
prevalences for five-year-old male children under scenarios (i) (left panels) and (ii) (right panels).
We observe that the point predictions for prevalence under the two models are strongly similar but
the joint model in (6.1), as expected, yields smaller standard errors throughout the study area.
Having chosen (6.1) as the best model, we compare the exceedance probabilities (EPs) for a
10% threshold between RDT and PCR. Using each of the two diagnostics, we then identify malaria
13
PCR - Predictions (joint mod.) PCR - Predictions (separate mod.)
RDT - Predictions (joint mod.) RDT - Predictions (separate mod.)
PCR - Std. errors (joint mod.) PCR - Std. errors (separate mod.)
RDT - Std. errors (joint mod.) RDT - Std. errors (separate mod.)
Figure 6.1: Point predictions (first and second rows) and standard errors (third and fourth rows) of
P. falciparum prevalence for five-year-old children under the joint geostatistical model in (6.1) (left
panels) and two separate geostatistical models (right panels) for RDT and PCR prevalence.
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hotspots, as the sets of locations such that their EP is at least 90%. Figure 7 of Web Appendix B
shows that PCR identifies a considerably larger hotspot in the north east of the study area than
does RDT, and a smaller hotspot in the south west that is undetected by RDT. These results are
consistent with the main findings of Mogeni et al. (2017).
7 Conclusions and extensions
We have developed a flexible geostatistical framework to model reported disease counts from mul-
tiple diagnostics and have distinguished two main classes of problems: (1) prediction of prevalence
as defined by a gold-standard diagnostic using data obtained from a more feasible low-cost, but
potentially biased, alternative; (2) joint prediction of prevalences as defined by two diagnostic tests.
As the burden of disease declines in endemic regions, the use of multiple transmission metrics and
diagnostics becomes necessary in order to better inform and adapt control strategies. It is thus
important to develop suitable methods of inference that allow the borrowing of strength of inform-
ation across multiple diagnostics. As our study has shown, the main benefit of this approach is a
reduction in the uncertainty associated with the predictive inferences on disease risk.
Our application to Loiasis mapping has shown the importance of acknowledging the existence of
residual spatial variation specific to each diagnostic test. Through a simulation study, we have also
shown that ignoring this source of extra-Binomial variation can lead to unreliably narrow prediction
intervals for prevalence, with actual coverages falling well below their nominal level.
The second application on malaria mapping has highlighted the benefits of a joint analysis of
data from two diagnostic tests when both are of scientific interest. A joint model can yield estimates
of prevalence with smaller standard errors than estimates obtained from two separate geostatistical
models.
Although we have only considered the case of two diagnostic tests throughout the paper, our
methodology can be easily extended to more than two. However, the nature of the extension will
be dependent on the specific context and scientific goal. For example, a natural extension of the
models of Section 4.1 would be to use multiple biased diagnostic tools (for k = 1, . . . ,K − 1) to
better predict a gold-standard (k = K). In this case, the cross-correlation between the outcomes of
the biased diagnostic tests could be modelled using the symmetric structure of the model in Section
4.2, while preserving an asymmetric form for the linear predictor of the gold-standard. Formally,
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this is expressed as

fk{pjk(xi)} = d>ijkβk + νk [Sk(xi) + T (xi)] + Zik, k = 1, . . . ,K − 1
fK{pjK(xi)} = d>ijKβK + SK(xi) + ZiK +
K−1∑
k=1
αkfk{pj(xi)}
. (7.1)
However, we would be wary of attempting to fit this, or other comparably complex models without
an initial exploratory analysis that might help to understand the extent of the cross-correlations
between the outcomes of different diagnostics, with a view to reducing the dimensionality of the
model.
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Table 1: Monte Carlo maximum likelihood estimates and associated 95% confidence intervals
for the fitted Model 1 and Model 2 to the Loa loa data; see Section 5 for more details.
Parameter Model 1 Model 2
β1,0 -0.791 -0.763
(-1.984, 0.402) (-1.963, 0.437)
β1,1 × 103 0.515 0.588
(-0.977, 2.008) (-0.922, 2.098)
β1,2 × 103 -3.529 -3.412
(-7.314, 0.255) (-7.155 , 0.331)
β1,3 × 103 -0.110 -0.059
(-1.531, 1.312) (-1.501 , 1.382)
β2,0 -1.762 -1.736
(-2.075, -1.449) (-2.244, -1.229)
β2,1 × 103 0.208 0.126
(-0.386, 0.802) (-0.799, 1.050)
β2,2 × 103 -0.223 -0.039
(-2.023, 1.576) (-2.944 , 2.865)
β2,3 × 103 -0.591 -0.612
(-1.666, 0.485) (-2.429, 1.205)
σ21 1.581 1.617
(0.669, 3.738) (0.679, 3.851)
σ22 — 0.216
(0.111, 0.419)
φ1 182.037 187.388
(64.657, 512.512) (65.171, 538.807)
φ2 — 23.686
(6.150, 91.220)
τ21 0.205 0.324
(0.081, 0.521) (0.052, 6.229)
τ22 0.324 0.104
(0.055, 5.873) (0.018, 5.797)
α 1.005 1.017
(0.902, 1.107) (0.939, 1.095)
Table 2: Results of the simulation study including the 95% coverage probability
(CP), the root-mean-square-error (RMSE), the 95% predictive interval length (PIL)
averaged over the 20 unobserved locations. For more details, see the main text in
Section 5.2.
CP RMSE PIL
Model 1 0.770 4.948 0.140
Model 2 0.943 3.932 0.185
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Table 3: Monte Carlo maximum likelihood estimates and associated 95% confidence
intervals for the model in (6.1) fitted to the malaria data.
Parameter RDT (k = 1) PCR (k = 2)
βk,0 -6.186 -4.373
(-7.234, -5.138) (-17.008, 8.261)
βk,1 -0.003 0.251
(-0.415, 0.395) (0.009, 0.494)
βk,2 0.261 0.220
(0.070, 0.453) (0.095, 0.344)
βk,3 -0.059 -0.020
(-0.081, -0.037) (-0.028, -0.012)
ν2k 0.230 0.081
(0.145, 0.364) (0.052, 0.126)
φT 11.581
(10.618, 12.63)
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